What Medical Weight Loss Means

Not all weight loss is created equal. Medically guided options offer clinically developed treatments supervised by professionals. These are ideal for those who need structure and support.

2. Approved and Regulated

Approval ensures you’re getting thoroughly tested treatments. These aren’t fads—they’re medical tools trusted by doctors across the U.S.

3. Top Medications You Should Know

Popular options include Semaglutide, Liraglutide, and other GLP-1 receptor agonists. These treatments help regulate hunger hormones and promote healthier eating habits.

4. The Criteria That Matters

Our comparisons are based on: cost, ease of refill, user ratings, time to results, and whether they’re suited for at-home or in-clinic use.

5. Finding the Right Match

Everyone’s needs differ. Our goal is to help you find a treatment that fits into your routine, budget, and medical profile.

6. Health Beyond The Scale

Medical weight loss isn’t just about pounds lost—it’s about managing blood pressure, cholesterol, blood sugar, and improving daily life.

7. Common Prescription-Based Weight Loss Medications in the U.S.

Several approved, prescription-only medications are widely used in the U.S. to help with medical weight management. Many of these work by affecting appetite-regulating hormones, particularly GLP-1 (glucagon-like peptide-1) receptor agonists. These treatments help users feel full longer, reduce hunger cues, and regulate glucose levels.

Here are the most commonly prescribed and effective options:


🔸 Semaglutide (brand names: Wegovy, Ozempic)

  • Class: GLP-1 Receptor Agonist
  • Use: Originally developed for type 2 diabetes (Ozempic), Semaglutide is now approved for weight loss under the brand Wegovy.
  • Effectiveness: Clinical trials show average weight loss of 12–15% of body weight over 68 weeks.

🔸 Liraglutide (brand name: Saxenda)

  • Class: GLP-1 Receptor Agonist
  • Use: Administered daily, Liraglutide is approved for chronic weight management and was one of the first GLP-1 medications with weight loss indication.
  • Effectiveness: Average body weight reduction of 8–10% when combined with lifestyle changes.

🔸 Tirzepatide (brand name: Zepbound, originally Mounjaro for diabetes)

  • Class: Dual GIP/GLP-1 Receptor Agonist
  • Use: Approved in 2023 under the name Zepbound for weight loss. It offers even greater results than previous options.
  • Effectiveness: Clinical data suggests 15–22% body weight loss, making it one of the most potent treatments currently available.

Note on Safety and Access

These medications are not over-the-counter and should only be used under the supervision of a licensed medical provider. Access often includes a prescription consultation, sometimes through telehealth platforms, and ongoing monitoring to assess tolerance and effectiveness.